title: PCSK9 Inhibitors for Statin Intolerance?
authors.affiliation: Division of Cardiology, San Francisco General Hospital, San Francisco, California2Department of Medicine, University of California-San Francisco.
authors.forename: David D
authors.initials: DD
authors.lastname: Waters
authors.affiliation: Division of Cardiology, San Francisco General Hospital, San Francisco, California2Department of Medicine, University of California-San Francisco.
authors.forename: Priscilla Y
authors.initials: PY
authors.lastname: Hsue
authors.affiliation: Division of Cardiology, New York University School of Medicine, New York, New York.
authors.forename: Sripal
authors.initials: S
authors.lastname: Bangalore
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D008078:Cholesterol, LDL / Q000097:blood*; D000069438:Ezetimibe / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy*; D008297:Male; D009135:Muscular Diseases / Q000517:prevention & control*
chemical_list: D000911:Antibodies, Monoclonal; D000924:Anticholesteremic Agents; D008078:Cholesterol, LDL; D000069438:Ezetimibe